CANTA.ST
Price:
$2.98
Market Cap:
$547.39M
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase IIa clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial. It is also developing CANxx antibodies against IL1RAP. The company has co...[Read more]
Industry
Biotechnology
IPO Date
2015-03-17
Stock Exchange
STO
Ticker
CANTA.ST
According to Cantargia AB (publ)’s latest financial reports and current stock price. The company's current ROE is -158.17%. This represents a change of 297.12% compared to the average of -39.83% of the last 4 quarters.
The mean historical ROE of Cantargia AB (publ) over the last ten years is -89.40%. The current -158.17% ROE has changed 76.92% with respect to the historical average. Over the past ten years (40 quarters), CANTA.ST's ROE was at its highest in in the March 2018 quarter at -5.89%. The ROE was at its lowest in in the December 2014 quarter at -62.17%.
Average
-89.40%
Median
-73.30%
Minimum
-204.28%
Maximum
-19.41%
Discovering the peaks and valleys of Cantargia AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 254.51%
Maximum Annual ROE = -19.41%
Minimum Annual Increase = -79.66%
Minimum Annual ROE = -204.28%
Year | ROE | Change |
---|---|---|
2023 | -165.95% | 78.60% |
2022 | -92.92% | 35.06% |
2021 | -68.80% | 254.51% |
2020 | -19.41% | -75.06% |
2019 | -77.80% | 32.33% |
2018 | -58.80% | 140.17% |
2017 | -24.48% | -79.66% |
2016 | -120.34% | 96.41% |
2015 | -61.27% | -70.01% |
2014 | -204.28% | -19.49% |
The current ROE of Cantargia AB (publ) (CANTA.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-109.22%
5-year avg
-84.97%
10-year avg
-89.40%
Cantargia AB (publ)’s ROE is less than Hansa Biopharma AB (publ) (242.32%), greater than Oncopeptides AB (publ) (-280.43%), greater than BioArctic AB (publ) (-8.62%), less than Alligator Bioscience AB (publ) (797.45%), greater than Saniona AB (publ) (-1729.06%),
Company | ROE | Market cap |
---|---|---|
242.32% | $2.19B | |
-280.43% | $438.37M | |
-8.62% | $12.56B | |
797.45% | $501.82M | |
-1729.06% | $355.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cantargia AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cantargia AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cantargia AB (publ)'s ROE?
How is the ROE calculated for Cantargia AB (publ) (CANTA.ST)?
What is the highest ROE for Cantargia AB (publ) (CANTA.ST)?
What is the 3-year average ROE for Cantargia AB (publ) (CANTA.ST)?
What is the 5-year average ROE for Cantargia AB (publ) (CANTA.ST)?
How does the current ROE for Cantargia AB (publ) (CANTA.ST) compare to its historical average?